The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer
Abstract
BACKGROUND: Castration‐resistant prostate cancer (CRPC) is a leading cause of cancer‐related deaths in elder men. This disease has limited therapeutic options and poor prognosis as the underlying molecular mechanisms are not clearly understood. Given the emerging roles of microRNA (miRNA) as a key regulator, we postulated that miRNA may play a significant role in CRPC formation. METHODS: miR‐146a levels in 15 androgen‐dependent prostate cancer (ADPC) tissues and 5 CRPC tissues were measured by qRT‐PCR. Effects of miR‐146a in cell proliferation and migration in vitro and in vivo were evaluated by MTT assay, colony formation assay, transwell migratory assay, and tumor formation assay, respectively. RESULTS: we found that miR‐146a expression was significantly decreased in CRPC tissues compared to ADPC tissues. Functional analyses showed that ectopic overexpression of miR‐146a in androgen‐independent cell lines not only inhibited cell growth, colony formation, and migration in vitro, but also reduced tumorigenicity and angiogenesis in vivo. Mechanistic studies revealed that miR‐146a repressed the expression of EGFR through binding to its 3′‐untranslated region. Also, miR‐146a inhibited the expression of MMP2, one of the most important genes in tumor progression. Moreover, downregulation of p‐ERK expression significantly abrogated miR‐146a‐induced prostate cancer cell proliferation. CONCLUSIONS: Our findings suggest that ubiquitous loss of miR‐146a is a critical mechanism for overexpression of EGFR in CRPC, which is crucial to better understanding the pathogenesis of CRPC. Prostate 72:1171–1178, 2012. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
MicroRNA targets in Drosophila
Enright, A. J., John, B., Gaul, U., Tuschl, T., Sander, C., & Marks, D. S. (2003) · Genome Biology · doi:10.1186/gb-2003-5-1-r1 · Cited by 3,597
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Cited by
Progress in corneal wound healing
Ljubimov, A. V., & Saghizadeh, M. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.002 · Cited by 872
Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
Chiyomaru, T., Yamamura, S., Fukuhara, S., Yoshino, H., Kinoshita, T., Majid, S., Saini, S., Chang, I., Tanaka, Y., Enokida, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070372 · Cited by 266
Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulation
Fischer, S., Handrick, R., Aschrafi, A., & Otte, K. (2015) · RNA Biology · doi:10.1080/15476286.2015.1017238 · Cited by 76
miRNAs as therapeutic tools and biomarkers for prostate cancer
Arrighetti, N., & Beretta, G. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030380 · Cited by 43
Rönnau, C. G. H., Fussek, S., Smit, F. P., Aalders, T. W., van Hooij, O., Pinto, P. M. C., Burchardt, M., Schalken, J. A., & Verhaegh, G. W. (2021) · World Journal of Urology · doi:10.1007/s00345-021-03723-4 · Cited by 28
Metadata
- Authors
- Xu, B., Wang, N., Wang, X., Tong, N., Shao, N., Tao, J., Li, P., Niu, X., Feng, N., Zhang, L., Hua, L., Wang, Z., & Chen, M.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2011-12-07
- Volume
- 72
- Issue
- 11
- Pages
- 1171-1178
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2012476517
- Cited by
- 167
- References
- 3
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer. https://app.cochat.ai/papers/10.1002/pros.22466
- The paper
- Xu, B., Wang, N., Wang, X., Tong, N., Shao, N., Tao, J., Li, P., Niu, X., Feng, N., Zhang, L., Hua, L., Wang, Z., & Chen, M. (2012). MiR‐146a suppresses tumor growth and progression by targeting EGFR pathway and in a p‐ERK‐dependent manner in castration‐resistant prostate cancer. The Prostate. https://doi.org/10.1002/pros.22466
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.